MedPage Today1d
FDA Panel Backs Cryoablation in Early Breast Cancer as Alternative to Surgery
An FDA panel on Thursday endorsed a cryoablation system as an alternative to surgery for some early breast cancer patients.
FDA Advisory Panel Votes in Favor of IceCure's ProSense® Cryoablation Benefit-Risk Profile in Early-Stage Low Risk Breast Cancer
IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive ...
Ice therapy shown to kill breast cancer tumors in new study: ‘Important technique’
Cryoablation, a minimally invasive technique, could provide a treatment alternative for patients who are not candidates for ...
MassDevice16d
Adagio has first case in IDE study for cryoablation tech
Adagio Medical (Nasdaq:ADGM) today announced the first completed procedure in an FDA IDE study of its VT cryoablation system.
Medscape1mon
Cryoablation versus Radiofrequency Ablation for Atrioventricular Nodal Reentrant Tachycardia: Patient Pain Perception and Operator Stress
Background: Cryoablation (CRYO) is an alternative to radiofrequency (RF) ablation in the treatment of atrioventricular nodal reentrant tachycardia (AVNRT). This study aims to evaluate the ...
Nature9y
Worse sexual function after cryoablation—a case for EBRT?
Cryoablation was performed using contemporary technology (TRUS [transrectal ultrasound] guidance with argon/helium third-generation equipment), and the study protocol allowed the procedure to be ...
Positive Outlook for IceCure Medical Driven by FDA Panel Support and Market Authorization
Yi Chen, an analyst from H.C. Wainwright, reiterated the Buy rating on Icecure Medical (ICCM – Research Report). The associated price ...
Icecure Medical’s ProSense System Gains Favorable FDA Panel Recommendation and Strong Financial Position Supports Buy Rating
Maxim Group analyst Anthony Vendetti reiterated a Buy rating on Icecure Medical (ICCM – Research Report) yesterday and set a price target ...
Icecure Receives Notice Of Allowance From U.S. Patent And Trademark Office For Its Next-Generation Cryoablation System
"With a patent portfolio of over 50 issued patents and the development of our next-generation systems, we continue to be an innovation leader in the cryoablation space. We are committed to fortifying ...
Morningstar17d
Adagio Medical Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation System
The Adagio Medical VT Cryoablation System with the vCLAS™ cryoablation1 catheter is based on the Company’s proprietary ultra-low temperature cryoablation (ULTC) technology and was designed ...